Production (Stage)
Ondine Biomedical Inc.
OBIMF
$0.14
$0.00392.87%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.72% | 228.07% | -73.45% | -72.58% | -76.72% |
| Total Receivables | 44.39% | 57.55% | 137.24% | 145.19% | 83.57% |
| Inventory | 9.51% | 19.49% | 14.54% | 18.29% | -15.57% |
| Prepaid Expenses | 98.98% | 117.16% | -27.82% | -25.48% | -40.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -7.06% | 1.38% | 0.09% | 3.41% | 9.48% |
| Total Current Assets | 135.51% | 156.93% | -49.79% | -48.14% | -67.82% |
|
|
|||||
| Total Current Assets | 135.51% | 156.93% | -49.79% | -48.14% | -67.82% |
| Net Property, Plant & Equipment | -42.26% | -37.01% | -36.19% | -34.11% | -30.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.02% | 5.79% | -0.38% | 2.70% | -0.38% |
| Total Assets | 105.24% | 123.91% | -47.42% | -45.70% | -64.53% |
|
|
|||||
| Total Accounts Payable | 6.80% | 16.51% | 682.10% | 707.96% | 259.99% |
| Total Accrued Expenses | 120.45% | 140.49% | -25.36% | -22.92% | -43.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -59.63% | -55.95% | -15.29% | -12.55% | 9.05% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 56.35% | 70.57% | 46.20% | 50.99% | -8.46% |
|
|
|||||
| Total Current Liabilities | 56.35% | 70.57% | 46.20% | 50.99% | -8.46% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -69.66% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 49.53% | 63.14% | 18.86% | 22.75% | -24.07% |
|
|
|||||
| Common Stock & APIC | 0.20% | 9.32% | 0.46% | 3.74% | 4.40% |
| Retained Earnings | 1.63% | -7.31% | -2.07% | -5.41% | -8.35% |
| Treasury Stock & Other | -3.50% | 5.28% | 0.68% | 3.97% | 3.89% |
| Total Common Equity | 202.73% | 230.27% | -99.56% | -99.54% | -81.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 202.73% | 230.27% | -99.56% | -99.54% | -81.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 202.73% | 230.27% | -99.56% | -99.54% | -81.65% |
|
|
|||||